Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial

• Main Authors: Tsen-Fang Tsai (Author), Min Zheng (Author), Yangfeng Ding (Author), Zhiqi Song (Author), Quanzhong Liu (Author), Ying Chen (Author), Hanzhao Hu (Author), Jinhua Xu (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening skin disease. The global Effisayil 1 study investigated the efficacy and safety of spesolimab, a humanized monoclonal antibody targeting the IL-36 receptor, in patients experiencing GPP flare. This...